Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Molenkamp, Barbara G
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jul 2008 - 4532-42 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
1078-0432
10.1158/1078-0432.CCR-07-4711 doi
Antigens, Neoplasm--immunology
CD8-Positive T-Lymphocytes--immunology
Chemotherapy, Adjuvant
Dendritic Cells--cytology
Flow Cytometry
Humans
Immunotherapy, Active--methods
Injections, Intralesional
Killer Cells, Natural--cytology
Melanoma--drug therapy
Middle Aged
Neoadjuvant Therapy
Oligodeoxyribonucleotides--administration & dosage
Sentinel Lymph Node Biopsy
Skin Neoplasms--drug therapy
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jul 2008 - 4532-42 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
1078-0432
10.1158/1078-0432.CCR-07-4711 doi
Antigens, Neoplasm--immunology
CD8-Positive T-Lymphocytes--immunology
Chemotherapy, Adjuvant
Dendritic Cells--cytology
Flow Cytometry
Humans
Immunotherapy, Active--methods
Injections, Intralesional
Killer Cells, Natural--cytology
Melanoma--drug therapy
Middle Aged
Neoadjuvant Therapy
Oligodeoxyribonucleotides--administration & dosage
Sentinel Lymph Node Biopsy
Skin Neoplasms--drug therapy